カテゴリー： LP Information, 世界, 医療/バイオ

世界の心不全治療薬市場予測 2021年-2026年

【英語タイトル】Global Heart Failure Therapeutics Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9550）・商品コード：LPI21MY9550
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：159
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「心不全治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、診断、予後、治療オプション・治療アルゴリズムなど、用途別には、病院、クリニック、医療研究機関などにセグメント区分してまとめました。心不全治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・心不全治療薬の世界市場概要（サマリー）
・心不全治療薬の企業別販売量・売上
・心不全治療薬の企業別市場シェア
・心不全治療薬の世界市場規模 2016年-2021年：種類別（診断、予後、治療オプション・治療アルゴリズム）
・心不全治療薬の世界市場規模 2016年-2021年：用途別（病院、クリニック、医療研究機関）
・心不全治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・心不全治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・心不全治療薬のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・心不全治療薬の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・心不全治療薬市場の成長要因・課題・動向
・心不全治療薬の世界市場予測 2021年-2026年
・心不全治療薬の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・心不全治療薬のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・心不全治療薬のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・心不全治療薬の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・心不全治療薬の世界市場予測：種類別（診断、予後、治療オプション・治療アルゴリズム）
・心不全治療薬の世界市場予測：用途別（病院、クリニック、医療研究機関）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Heart Failure Therapeutics will have significant change from previous year. By the most conservative estimates of global Heart Failure Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Heart Failure Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Heart Failure Therapeutics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Diagnosis
Prognosis
Treatment Options and Treatment Algorithm

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic
Medical Research Organization

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Bayer
Cynokinetics
Les Laboratoires Servier
Merck & Co.
Novartis
Procoralan
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Orion Corporation
PhaseBio Pharmaceuticals
Market Segment by Product Type
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Heart Failure Therapeutics Consumption 2016-2026
2.1.2 Heart Failure Therapeutics Consumption CAGR by Region
2.2 Heart Failure Therapeutics Segment by Type
2.2.1 Diagnosis
2.2.2 Prognosis
2.2.3 Treatment Options and Treatment Algorithm
2.3 Heart Failure Therapeutics Sales by Type
2.3.1 Global Heart Failure Therapeutics Sales Market Share by Type (2016-2021)
2.3.2 Global Heart Failure Therapeutics Revenue and Market Share by Type (2016-2021)
2.3.3 Global Heart Failure Therapeutics Sale Price by Type (2016-2021)
2.4 Heart Failure Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Medical Research Organization
2.5 Heart Failure Therapeutics Sales by Application
2.5.1 Global Heart Failure Therapeutics Sale Market Share by Application (2016-2021)
2.5.2 Global Heart Failure Therapeutics Revenue and Market Share by Application (2016-2021)
2.5.3 Global Heart Failure Therapeutics Sale Price by Application (2016-2021)

3 Global Heart Failure Therapeutics by Company
3.1 Global Heart Failure Therapeutics Sales Market Share by Company
3.1.1 Global Heart Failure Therapeutics Sales by Company (2019-2021)
3.1.2 Global Heart Failure Therapeutics Sales Market Share by Company (2019-2021)
3.2 Global Heart Failure Therapeutics Revenue Market Share by Company
3.2.1 Global Heart Failure Therapeutics Revenue by Company (2019-2021)
3.2.2 Global Heart Failure Therapeutics Revenue Market Share by Company (2019-2021)
3.3 Global Heart Failure Therapeutics Sale Price by Company
3.4 Global Manufacturers Heart Failure Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Heart Failure Therapeutics Product Location Distribution
3.4.2 Players Heart Failure Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Heart Failure Therapeutics by Region
4.1 Global Heart Failure Therapeutics by Region
4.1.1 Global Heart Failure Therapeutics Sales by Region
4.1.2 Global Heart Failure Therapeutics Revenue by Region
4.2 Americas Heart Failure Therapeutics Sales Growth
4.3 APAC Heart Failure Therapeutics Sales Growth
4.4 Europe Heart Failure Therapeutics Sales Growth
4.5 Middle East & Africa Heart Failure Therapeutics Sales Growth

5 Americas
5.1 Americas Heart Failure Therapeutics Sales by Country
5.1.1 Americas Heart Failure Therapeutics Sales by Country (2016-2021)
5.1.2 Americas Heart Failure Therapeutics Revenue by Country (2016-2021)
5.2 Americas Heart Failure Therapeutics Sales by Type
5.3 Americas Heart Failure Therapeutics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Heart Failure Therapeutics Sales by Region
6.1.1 APAC Heart Failure Therapeutics Sales by Region (2016-2021)
6.1.2 APAC Heart Failure Therapeutics Revenue by Region (2016-2021)
6.2 APAC Heart Failure Therapeutics Sales by Type
6.3 APAC Heart Failure Therapeutics Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Heart Failure Therapeutics by Country
7.1.1 Europe Heart Failure Therapeutics Sales by Country (2016-2021)
7.1.2 Europe Heart Failure Therapeutics Revenue by Country (2016-2021)
7.2 Europe Heart Failure Therapeutics Sales by Type
7.3 Europe Heart Failure Therapeutics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Heart Failure Therapeutics by Country
8.1.1 Middle East & Africa Heart Failure Therapeutics Sales by Country (2016-2021)
8.1.2 Middle East & Africa Heart Failure Therapeutics Revenue by Country (2016-2021)
8.2 Middle East & Africa Heart Failure Therapeutics Sales by Type
8.3 Middle East & Africa Heart Failure Therapeutics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Heart Failure Therapeutics Distributors
10.3 Heart Failure Therapeutics Customer

11 Global Heart Failure Therapeutics Market Forecast
11.1 Global Heart Failure Therapeutics Forecast by Region
11.1.1 Global Heart Failure Therapeutics Forecast by Regions (2021-2026)
11.2.2 Global Heart Failure Therapeutics Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Heart Failure Therapeutics Forecast by Type
11.7 Global Heart Failure Therapeutics Forecast by Application

12 Key Players Analysis
12.1 Bayer
12.1.1 Bayer Bayer Company Information
12.1.2 Bayer Heart Failure Therapeutics Product Offered
12.1.3 Bayer Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bayer Main Business Overview
12.1.5 Bayer Latest Developments
12.2 Cynokinetics
12.2.1 Cynokinetics Company Information
12.2.2 Cynokinetics Heart Failure Therapeutics Product Offered
12.2.3 Cynokinetics Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Cynokinetics Main Business Overview
12.2.5 Cynokinetics Latest Developments
12.3 Les Laboratoires Servier
12.3.1 Les Laboratoires Servier Company Information
12.3.2 Les Laboratoires Servier Heart Failure Therapeutics Product Offered
12.3.3 Les Laboratoires Servier Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Les Laboratoires Servier Main Business Overview
12.3.5 Les Laboratoires Servier Latest Developments
12.4 Merck & Co.
12.4.1 Merck & Co. Company Information
12.4.2 Merck & Co. Heart Failure Therapeutics Product Offered
12.4.3 Merck & Co. Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Merck & Co. Main Business Overview
12.4.5 Merck & Co. Latest Developments
12.5 Novartis
12.5.1 Novartis Company Information
12.5.2 Novartis Heart Failure Therapeutics Product Offered
12.5.3 Novartis Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Novartis Main Business Overview
12.5.5 Novartis Latest Developments
12.6 Procoralan
12.6.1 Procoralan Company Information
12.6.2 Procoralan Heart Failure Therapeutics Product Offered
12.6.3 Procoralan Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Procoralan Main Business Overview
12.6.5 Procoralan Latest Developments
12.7 Bristol-Myers Squibb Company
12.7.1 Bristol-Myers Squibb Company Company Information
12.7.2 Bristol-Myers Squibb Company Heart Failure Therapeutics Product Offered
12.7.3 Bristol-Myers Squibb Company Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Bristol-Myers Squibb Company Main Business Overview
12.7.5 Bristol-Myers Squibb Company Latest Developments
12.8 Cardiorentis AG
12.8.1 Cardiorentis AG Company Information
12.8.2 Cardiorentis AG Heart Failure Therapeutics Product Offered
12.8.3 Cardiorentis AG Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Cardiorentis AG Main Business Overview
12.8.5 Cardiorentis AG Latest Developments
12.9 CVie Therapeutics Limited
12.9.1 CVie Therapeutics Limited Company Information
12.9.2 CVie Therapeutics Limited Heart Failure Therapeutics Product Offered
12.9.3 CVie Therapeutics Limited Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 CVie Therapeutics Limited Main Business Overview
12.9.5 CVie Therapeutics Limited Latest Developments
12.10 Orion Corporation
12.10.1 Orion Corporation Company Information
12.10.2 Orion Corporation Heart Failure Therapeutics Product Offered
12.10.3 Orion Corporation Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Orion Corporation Main Business Overview
12.10.5 Orion Corporation Latest Developments
12.11 PhaseBio Pharmaceuticals
12.11.1 PhaseBio Pharmaceuticals Company Information
12.11.2 PhaseBio Pharmaceuticals Heart Failure Therapeutics Product Offered
12.11.3 PhaseBio Pharmaceuticals Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 PhaseBio Pharmaceuticals Main Business Overview
12.11.5 PhaseBio Pharmaceuticals Latest Developments
12.12 Market Segment by Product Type
12.12.1 Market Segment by Product Type Company Information
12.12.2 Market Segment by Product Type Heart Failure Therapeutics Product Offered
12.12.3 Market Segment by Product Type Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Market Segment by Product Type Main Business Overview
12.12.5 Market Segment by Product Type Latest Developments
12.13 B-Blockers
12.13.1 B-Blockers Company Information
12.13.2 B-Blockers Heart Failure Therapeutics Product Offered
12.13.3 B-Blockers Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 B-Blockers Main Business Overview
12.13.5 B-Blockers Latest Developments
12.14 Calcium Channel Blockers
12.14.1 Calcium Channel Blockers Company Information
12.14.2 Calcium Channel Blockers Heart Failure Therapeutics Product Offered
12.14.3 Calcium Channel Blockers Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Calcium Channel Blockers Main Business Overview
12.14.5 Calcium Channel Blockers Latest Developments
12.15 Cardiac Glycosides
12.15.1 Cardiac Glycosides Company Information
12.15.2 Cardiac Glycosides Heart Failure Therapeutics Product Offered
12.15.3 Cardiac Glycosides Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Cardiac Glycosides Main Business Overview
12.15.5 Cardiac Glycosides Latest Developments
12.16 Diuretics
12.16.1 Diuretics Company Information
12.16.2 Diuretics Heart Failure Therapeutics Product Offered
12.16.3 Diuretics Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Diuretics Main Business Overview
12.16.5 Diuretics Latest Developments
12.17 Morphine
12.17.1 Morphine Company Information
12.17.2 Morphine Heart Failure Therapeutics Product Offered
12.17.3 Morphine Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Morphine Main Business Overview
12.17.5 Morphine Latest Developments
12.18 Vasodilators/Nitrates
12.18.1 Vasodilators/Nitrates Company Information
12.18.2 Vasodilators/Nitrates Heart Failure Therapeutics Product Offered
12.18.3 Vasodilators/Nitrates Heart Failure Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Vasodilators/Nitrates Main Business Overview
12.18.5 Vasodilators/Nitrates Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Heart Failure Therapeutics Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Diagnosis
Table 3. Major Players of Prognosis
Table 4. Major Players of Treatment Options and Treatment Algorithm
Table 5. Global Heart Failure Therapeutics Sales by Type (2016-2021) & (K Units)
Table 6. Global Heart Failure Therapeutics Sales Market Share by Type (2016-2021)
Table 7. Global Heart Failure Therapeutics Revenue by Type (2016-2021) & ($ million)
Table 8. Global Heart Failure Therapeutics Revenue Market Share by Type (2016-2021)
Table 9. Global Heart Failure Therapeutics Sale Price by Type (2016-2021)
Table 10. Global Heart Failure Therapeutics Sales by Application (2016-2021) & (K Units)
Table 11. Global Heart Failure Therapeutics Sales Market Share by Application (2016-2021)
Table 12. Global Heart Failure Therapeutics Value by Application (2016-2021)
Table 13. Global Heart Failure Therapeutics Revenue Market Share by Application (2016-2021)
Table 14. Global Heart Failure Therapeutics Sale Price by Application (2016-2021)
Table 15. Global Heart Failure Therapeutics Sales by Company (2019-2021) & (K Units)
Table 16. Global Heart Failure Therapeutics Sales Market Share by Company (2019-2021)
Table 17. Global Heart Failure Therapeutics Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Heart Failure Therapeutics Revenue Market Share by Company (2019-2021)
Table 19. Global Heart Failure Therapeutics Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Heart Failure Therapeutics Producing Area Distribution and Sales Area
Table 21. Players Heart Failure Therapeutics Products Offered
Table 22. Heart Failure Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Heart Failure Therapeutics Sales by Region (2016-2021) (K Units)
Table 26. Global Heart Failure Therapeutics Sales Market Share by Region (2016-2021)
Table 27. Global Heart Failure Therapeutics Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Heart Failure Therapeutics Revenue Market Share by Region (2016-2021)
Table 29. Americas Heart Failure Therapeutics Sales by Country (2016-2021) & (K Units)
Table 30. Americas Heart Failure Therapeutics Sales Market Share by Country (2016-2021)
Table 31. Americas Heart Failure Therapeutics Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Heart Failure Therapeutics Revenue Market Share by Country (2016-2021)
Table 33. Americas Heart Failure Therapeutics Sales by Type (2016-2021) & (K Units)
Table 34. Americas Heart Failure Therapeutics Sales Market Share by Type (2016-2021)
Table 35. Americas Heart Failure Therapeutics Sales by Application (2016-2021) & (K Units)
Table 36. Americas Heart Failure Therapeutics Sales Market Share by Application (2016-2021)
Table 37. APAC Heart Failure Therapeutics Sales by Region (2016-2021) & (K Units)
Table 38. APAC Heart Failure Therapeutics Sales Market Share by Region (2016-2021)
Table 39. APAC Heart Failure Therapeutics Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Heart Failure Therapeutics Revenue Market Share by Region (2016-2021)
Table 41. APAC Heart Failure Therapeutics Sales by Type (2016-2021) & (K Units)
Table 42. APAC Heart Failure Therapeutics Sales Market Share by Type (2016-2021)
Table 43. APAC Heart Failure Therapeutics Sales by Application (2016-2021) & (K Units)
Table 44. APAC Heart Failure Therapeutics Sales Market Share by Application (2016-2021)
Table 45. Europe Heart Failure Therapeutics Sales by Country (2016-2021) & (K Units)
Table 46. Europe Heart Failure Therapeutics Sales Market Share by Country (2016-2021)
Table 47. Europe Heart Failure Therapeutics Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Heart Failure Therapeutics Revenue Market Share by Country (2016-2021)
Table 49. Europe Heart Failure Therapeutics Sales by Type (2016-2021) & (K Units)
Table 50. Europe Heart Failure Therapeutics Sales Market Share by Type (2016-2021)
Table 51. Europe Heart Failure Therapeutics Sales by Application (2016-2021) & (K Units)
Table 52. Europe Heart Failure Therapeutics Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Heart Failure Therapeutics Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Heart Failure Therapeutics Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Heart Failure Therapeutics Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Heart Failure Therapeutics Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Heart Failure Therapeutics Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Heart Failure Therapeutics Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Heart Failure Therapeutics Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Heart Failure Therapeutics Sales Market Share by Application (2016-2021)
Table 61. Global Heart Failure Therapeutics Sales Forecast by Type (2021-2026) & (K Units)
Table 62. Global Heart Failure Therapeutics Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Heart Failure Therapeutics Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Heart Failure Therapeutics Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Heart Failure Therapeutics Sales Forecast by Application (2021-2026) & (K Units)
Table 66. Global Heart Failure Therapeutics Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Heart Failure Therapeutics Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Heart Failure Therapeutics Revenue Market Share Forecast by Application (2021-2026)
Table 69. Bayer Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 70. Bayer Heart Failure Therapeutics Product Offered
Table 71. Bayer Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 72. Bayer Main Business
Table 73. Bayer Latest Developments
Table 74. Cynokinetics Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 75. Cynokinetics Heart Failure Therapeutics Product Offered
Table 76. Cynokinetics Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 77. Cynokinetics Main Business
Table 78. Cynokinetics Latest Developments
Table 79. Les Laboratoires Servier Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 80. Les Laboratoires Servier Heart Failure Therapeutics Product Offered
Table 81. Les Laboratoires Servier Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 82. Les Laboratoires Servier Main Business
Table 83. Les Laboratoires Servier Latest Developments
Table 84. Merck & Co. Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck & Co. Heart Failure Therapeutics Product Offered
Table 86. Merck & Co. Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 87. Merck & Co. Main Business
Table 88. Merck & Co. Latest Developments
Table 89. Novartis Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 90. Novartis Heart Failure Therapeutics Product Offered
Table 91. Novartis Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 92. Novartis Main Business
Table 93. Novartis Latest Developments
Table 94. Procoralan Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 95. Procoralan Heart Failure Therapeutics Product Offered
Table 96. Procoralan Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 97. Procoralan Main Business
Table 98. Procoralan Latest Developments
Table 99. Bristol-Myers Squibb Company Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 100. Bristol-Myers Squibb Company Heart Failure Therapeutics Product Offered
Table 101. Bristol-Myers Squibb Company Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 102. Bristol-Myers Squibb Company Main Business
Table 103. Bristol-Myers Squibb Company Latest Developments
Table 104. Cardiorentis AG Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 105. Cardiorentis AG Heart Failure Therapeutics Product Offered
Table 106. Cardiorentis AG Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 107. Cardiorentis AG Main Business
Table 108. Cardiorentis AG Latest Developments
Table 109. CVie Therapeutics Limited Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 110. CVie Therapeutics Limited Heart Failure Therapeutics Product Offered
Table 111. CVie Therapeutics Limited Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 112. CVie Therapeutics Limited Main Business
Table 113. CVie Therapeutics Limited Latest Developments
Table 114. Orion Corporation Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 115. Orion Corporation Heart Failure Therapeutics Product Offered
Table 116. Orion Corporation Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 117. Orion Corporation Main Business
Table 118. Orion Corporation Latest Developments
Table 119. PhaseBio Pharmaceuticals Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 120. PhaseBio Pharmaceuticals Heart Failure Therapeutics Product Offered
Table 121. PhaseBio Pharmaceuticals Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 122. PhaseBio Pharmaceuticals Main Business
Table 123. PhaseBio Pharmaceuticals Latest Developments
Table 124. Market Segment by Product Type Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 125. Market Segment by Product Type Heart Failure Therapeutics Product Offered
Table 126. Market Segment by Product Type Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 127. Market Segment by Product Type Main Business
Table 128. Market Segment by Product Type Latest Developments
Table 129. B-Blockers Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 130. B-Blockers Heart Failure Therapeutics Product Offered
Table 131. B-Blockers Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 132. B-Blockers Main Business
Table 133. B-Blockers Latest Developments
Table 134. Calcium Channel Blockers Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 135. Calcium Channel Blockers Heart Failure Therapeutics Product Offered
Table 136. Calcium Channel Blockers Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 137. Calcium Channel Blockers Main Business
Table 138. Calcium Channel Blockers Latest Developments
Table 139. Cardiac Glycosides Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 140. Cardiac Glycosides Heart Failure Therapeutics Product Offered
Table 141. Cardiac Glycosides Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 142. Cardiac Glycosides Main Business
Table 143. Cardiac Glycosides Latest Developments
Table 144. Diuretics Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 145. Diuretics Heart Failure Therapeutics Product Offered
Table 146. Diuretics Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 147. Diuretics Main Business
Table 148. Diuretics Latest Developments
Table 149. Morphine Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 150. Morphine Heart Failure Therapeutics Product Offered
Table 151. Morphine Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 152. Morphine Main Business
Table 153. Morphine Latest Developments
Table 154. Vasodilators/Nitrates Basic Information, Heart Failure Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 155. Vasodilators/Nitrates Heart Failure Therapeutics Product Offered
Table 156. Vasodilators/Nitrates Heart Failure Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 157. Vasodilators/Nitrates Main Business
Table 158. Vasodilators/Nitrates Latest Developments
List of Figures
Figure 1. Picture of Heart Failure Therapeutics
Figure 2. Heart Failure Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Heart Failure Therapeutics Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Heart Failure Therapeutics Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Heart Failure Therapeutics Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Diagnosis
Figure 10. Product Picture of Prognosis
Figure 11. Product Picture of Treatment Options and Treatment Algorithm
Figure 12. Global Heart Failure Therapeutics Sales Market Share by Type in 2020
Figure 13. Global Heart Failure Therapeutics Revenue Market Share by Type (2016-2021)
Figure 14. Heart Failure Therapeutics Consumed in Hospital
Figure 15. Global Heart Failure Therapeutics Market: Hospital (2016-2021) & (K Units)
Figure 16. Heart Failure Therapeutics Consumed in Clinic
Figure 17. Global Heart Failure Therapeutics Market: Clinic (2016-2021) & (K Units)
Figure 18. Heart Failure Therapeutics Consumed in Medical Research Organization
Figure 19. Global Heart Failure Therapeutics Market: Medical Research Organization (2016-2021) & (K Units)
Figure 20. Global Heart Failure Therapeutics Sales Market Share by Application (2016-2021)
Figure 21. Global Heart Failure Therapeutics Revenue Market Share by Application in 2020
Figure 22. Global Heart Failure Therapeutics Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Heart Failure Therapeutics Revenue Market Share by Company in 2020
Figure 24. Global Heart Failure Therapeutics Sales Market Share by Regions (2016-2021)
Figure 25. Global Heart Failure Therapeutics Revenue Market Share by Region in 2020
Figure 26. Americas Heart Failure Therapeutics Sales 2016-2021 (K Units)
Figure 27. Americas Heart Failure Therapeutics Revenue 2016-2021 ($ Millions)
Figure 28. APAC Heart Failure Therapeutics Sales 2016-2021 (K Units)
Figure 29. APAC Heart Failure Therapeutics Revenue 2016-2021 ($ Millions)
Figure 30. Europe Heart Failure Therapeutics Sales 2016-2021 (K Units)
Figure 31. Europe Heart Failure Therapeutics Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Heart Failure Therapeutics Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Heart Failure Therapeutics Revenue 2016-2021 ($ Millions)
Figure 34. Americas Heart Failure Therapeutics Sales Market Share by Country in 2020
Figure 35. Americas Heart Failure Therapeutics Revenue Market Share by Country in 2020
Figure 36. Americas Heart Failure Therapeutics Sales Market Share by Type in 2020
Figure 37. Americas Heart Failure Therapeutics Sales Market Share by Application in 2020
Figure 38. United States Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Heart Failure Therapeutics Sales Market Share by Region in 2020
Figure 43. APAC Heart Failure Therapeutics Revenue Market Share by Regions in 2020
Figure 44. APAC Heart Failure Therapeutics Sales Market Share by Type in 2020
Figure 45. APAC Heart Failure Therapeutics Sales Market Share by Application in 2020
Figure 46. China Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Heart Failure Therapeutics Sales Market Share by Country in 2020
Figure 53. Europe Heart Failure Therapeutics Revenue Market Share by Country in 2020
Figure 54. Europe Heart Failure Therapeutics Sales Market Share by Type in 2020
Figure 55. Europe Heart Failure Therapeutics Sales Market Share by Application in 2020
Figure 56. Germany Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Heart Failure Therapeutics Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Heart Failure Therapeutics Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Heart Failure Therapeutics Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Heart Failure Therapeutics Sales Market Share by Application in 2020
Figure 65. Egypt Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Heart Failure Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles


★調査レポート[世界の心不全治療薬市場予測 2021年-2026年] (コード：LPI21MY9550)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の心不全治療薬市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の人工心肺装置市場予測 2021年-2026年
    LPI21MY8729 / LP Information / 2021年5月 / LPインフォメーション社の「人工心肺装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、シングルローラーポンプ、ダブルローラーポンプなど、用途別には、心臓手術、肺移植手術、急性呼吸不全治療、その他などにセグメント区分してまとめました。人工心肺装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・人工心肺装置の世界市場概要（サマリー） ・人工心肺装置の企業別販売量・売上 ・人工心肺装置の企業別市場シェア ・人工心肺装置の世界市場規模 2016年-2021年：種類別（シングルローラーポンプ、ダブルローラーポンプ） ・人工心肺装置の世界市場規模 2016年-2021年：用途別（心臓手術、肺移植手術、急性呼吸不全治療、その他） ・人工心肺装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・人工心肺装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Artificial Heart-Lung Machine will have significant change from previous year. By the most conservative estimates of global Artificial Heart-Lung Machine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 257.2 million in 2019. Over the next five years the Artificial Heart-Lung Machine market will register a 2.9% CAGR in terms of revenue, the global market size will reach US$ 288.5 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Heart-Lung Machine market by product type,...
  • 世界の心臓用ステント市場予測 2021年-2026年
    LPI21MY9000 / LP Information / 2021年5月 / LPインフォメーション社の「心臓用ステントの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、薬剤溶出性ステント、ベアメタルステント、生物活性ステント、放射性ステントなど、用途別には、急性心筋梗塞、不安定狭心症、狭心症などにセグメント区分してまとめました。心臓用ステントのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心臓用ステントの世界市場概要（サマリー） ・心臓用ステントの企業別販売量・売上 ・心臓用ステントの企業別市場シェア ・心臓用ステントの世界市場規模 2016年-2021年：種類別（薬剤溶出性ステント、ベアメタルステント、生物活性ステント、放射性ステント） ・心臓用ステントの世界市場規模 2016年-2021年：用途別（急性心筋梗塞、不安定狭心症、狭心症） ・心臓用ステントの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心臓用ステントのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Heart Stent will have significant change from previous year. By the most conservative estimates of global Heart Stent market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Heart Stent market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Heart Stent market by product type, application, key manufacturers and...
  • 世界の開心術用バルブ市場予測 2021年-2026年
    LPI21MY9153 / LP Information / 2021年5月 / LPインフォメーション社の「開心術用バルブの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、機械式バルブ、TAVRバルブなど、用途別には、病院、診療所、その他などにセグメント区分してまとめました。開心術用バルブのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・開心術用バルブの世界市場概要（サマリー） ・開心術用バルブの企業別販売量・売上 ・開心術用バルブの企業別市場シェア ・開心術用バルブの世界市場規模 2016年-2021年：種類別（機械式バルブ、TAVRバルブ） ・開心術用バルブの世界市場規模 2016年-2021年：用途別（病院、診療所、その他） ・開心術用バルブの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・開心術用バルブのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Open Surgery Heart Valves will have significant change from previous year. By the most conservative estimates of global Open Surgery Heart Valves market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Open Surgery Heart Valves market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Open Surgery Heart Valves...
  • 世界の急性心不全(AHF)治療薬市場 2019年
    DATA909X02947 / QYResearch / 2019年11月15日 / ※本調査レポートは、急性心不全(AHF)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、β遮断薬、カルシウム拮抗薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他に、用途別には、病院、クリニック、ホームケアにセグメント区分し、急性心不全(AHF)治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・急性心不全(AHF)治療薬の世界市場概要 ・急性心不全(AHF)治療薬の製造コスト構成分析 ・急性心不全(AHF)治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・急性心不全(AHF)治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・急性心不全(AHF)治療薬のセグメント分析（種類別） （β遮断薬、カルシウム拮抗薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他）...The global Acute Heart Failure (AHF) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Heart Failure (AHF) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Heart Failure (AHF) Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Acute Heart Failure (AHF) Therapeutics in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のハンセン病治療薬市場予測 2021年-2026年
    LPI21MY9549 / LP Information / 2021年5月 / LPインフォメーション社の「ハンセン病治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、クロファジミン、サリドマイド、その他など、用途別には、病院、クリニック、その他などにセグメント区分してまとめました。ハンセン病治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ハンセン病治療薬の世界市場概要（サマリー） ・ハンセン病治療薬の企業別販売量・売上 ・ハンセン病治療薬の企業別市場シェア ・ハンセン病治療薬の世界市場規模 2016年-2021年：種類別（クロファジミン、サリドマイド、その他） ・ハンセン病治療薬の世界市場規模 2016年-2021年：用途別（病院、クリニック、その他） ・ハンセン病治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ハンセン病治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Hansen's Disease Therapeutics will have significant change from previous year. By the most conservative estimates of global Hansen's Disease Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hansen's Disease Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Hansen's Disease Therapeutics market by product type,...
  • 世界の生物学的治療薬市場予測 2021年-2026年
    LPI21MY9447 / LP Information / 2021年5月 / LPインフォメーション社の「生物学的治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ヒト、鳥類細胞培養、酵母、細菌、昆虫細胞培養、トランスジェニックなど、用途別には、関節リウマチ、貧血、がん、糖尿病、その他などにセグメント区分してまとめました。生物学的治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・生物学的治療薬の世界市場概要（サマリー） ・生物学的治療薬の企業別販売量・売上 ・生物学的治療薬の企業別市場シェア ・生物学的治療薬の世界市場規模 2016年-2021年：種類別（ヒト、鳥類細胞培養、酵母、細菌、昆虫細胞培養、トランスジェニック） ・生物学的治療薬の世界市場規模 2016年-2021年：用途別（関節リウマチ、貧血、がん、糖尿病、その他） ・生物学的治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・生物学的治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Biologic Therapeutics Drugs will have significant change from previous year. By the most conservative estimates of global Biologic Therapeutics Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 315410 million in 2019. Over the next five years the Biologic Therapeutics Drugs market will register a 6.2% CAGR in terms of revenue, the global market size will reach US$ 401730 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Therapeutics Drugs market by product type,...
  • 世界の心血管疾患治療薬市場予測 2021年-2026年
    LPI21MY9466 / LP Information / 2021年5月 / LPインフォメーション社の「心血管疾患治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ヘパリン、クマディン、セクトラル、ゼベタ、ロプレッサー、トプロロールXL、ノルバスク、ロットレル、その他など、用途別には、虚血性心疾患、脂質異常症、脳卒中、血栓症、アテローム性動脈硬化症、冠状動脈疾患、末梢動脈疾患、その他などにセグメント区分してまとめました。心血管疾患治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心血管疾患治療薬の世界市場概要（サマリー） ・心血管疾患治療薬の企業別販売量・売上 ・心血管疾患治療薬の企業別市場シェア ・心血管疾患治療薬の世界市場規模 2016年-2021年：種類別（ヘパリン、クマディン、セクトラル、ゼベタ、ロプレッサー、トプロロールXL、ノルバスク、ロットレル、その他） ・心血管疾患治療薬の世界市場規模 2016年-2021年：用途別（虚血性心疾患、脂質異常症、脳卒中、血栓症、アテローム性動脈硬化症、冠状動脈疾患、末梢動脈疾患、その他） ・心血管疾患治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心血管疾患治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cardiovascular Disease Drugs will have significant change from previous year. By the most conservative estimates of global Cardiovascular Disease Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cardiovascular Disease Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Disease Drugs market by product type,...
  • 世界の心臓用機器市場予測 2021年-2026年
    LPI21MY8804 / LP Information / 2021年5月 / LPインフォメーション社の「心臓用機器の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、バルーンポンプ、心肺バイパスポンプ、心臓超音波装置、CRTペースメーカー（CRT-P）、CRT除細動器（CRT-D）、除細動器、ペースメーカー、補助人工心臓、その他など、用途別には、病院、家庭などにセグメント区分してまとめました。心臓用機器のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心臓用機器の世界市場概要（サマリー） ・心臓用機器の企業別販売量・売上 ・心臓用機器の企業別市場シェア ・心臓用機器の世界市場規模 2016年-2021年：種類別（バルーンポンプ、心肺バイパスポンプ、心臓超音波装置、CRTペースメーカー（CRT-P）、CRT除細動器（CRT-D）、除細動器、ペースメーカー、補助人工心臓、その他） ・心臓用機器の世界市場規模 2016年-2021年：用途別（病院、家庭） ・心臓用機器の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心臓用機器のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cardiac Equipment will have significant change from previous year. By the most conservative estimates of global Cardiac Equipment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 55250 million in 2019. Over the next five years the Cardiac Equipment market will register a 3.1% CAGR in terms of revenue, the global market size will reach US$ 62470 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Equipment market by product type, application, key manufacturers and...
  • 世界のカリウムチャネル遮断薬市場予測 2021年-2026年
    LPI21MY9629 / LP Information / 2021年5月 / LPインフォメーション社の「カリウムチャネル遮断薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、臨床的、非臨床的、不活性など、用途別には、診療所、病院などにセグメント区分してまとめました。カリウムチャネル遮断薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・カリウムチャネル遮断薬の世界市場概要（サマリー） ・カリウムチャネル遮断薬の企業別販売量・売上 ・カリウムチャネル遮断薬の企業別市場シェア ・カリウムチャネル遮断薬の世界市場規模 2016年-2021年：種類別（臨床的、非臨床的、不活性） ・カリウムチャネル遮断薬の世界市場規模 2016年-2021年：用途別（診療所、病院） ・カリウムチャネル遮断薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・カリウムチャネル遮断薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Potassium Channel Blocker will have significant change from previous year. By the most conservative estimates of global Potassium Channel Blocker market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Potassium Channel Blocker market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Potassium Channel Blocker market by product type,...
  • 世界の不眠症治療薬市場予測 2021年-2026年
    LPI21MY9648 / LP Information / 2021年5月 / LPインフォメーション社の「不眠症治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、非ベンゾジアゼピン受容体作動薬、ベンゾジアゼピン受容体作動薬、選択的メラトニン受容体作動薬ラメルテオン、鎮静抗うつ薬など、用途別には、大人、子供などにセグメント区分してまとめました。不眠症治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・不眠症治療薬の世界市場概要（サマリー） ・不眠症治療薬の企業別販売量・売上 ・不眠症治療薬の企業別市場シェア ・不眠症治療薬の世界市場規模 2016年-2021年：種類別（非ベンゾジアゼピン受容体作動薬、ベンゾジアゼピン受容体作動薬、選択的メラトニン受容体作動薬ラメルテオン、鎮静抗うつ薬） ・不眠症治療薬の世界市場規模 2016年-2021年：用途別（大人、子供） ・不眠症治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・不眠症治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Insomnia Medication will have significant change from previous year. By the most conservative estimates of global Insomnia Medication market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Insomnia Medication market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Insomnia Medication market by product type, application, key manufacturers and...

    • ◆H&Iグローバルリサーチのお客様（例）◆